Nesyrgy (Amlodipine Besilate, Nebivolol Hydrochloride)

Amlodipine besilate is a dihydropyridine calcium‑channel blocker that inhibits L‑type calcium channels in vascular smooth muscle. This inhibition prevents calcium influx, leading to relaxation of arterial walls, decreased peripheral resistance, and ultimately lower systolic and diastolic blood pressure.

The appropriate dose of Nesyrgy is determined by the prescribing healthcare professional based on the patient’s clinical condition, response to therapy, and any concomitant medications. Dosage adjustments are made individually; patients should follow the prescriber’s instructions and not alter the dose on their own.

The safety of Nesyrgy in pregnancy and lactation has not been established. Because the effects on the fetus or infant are unknown, it should only be used if the potential benefit justifies the potential risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To order Nesyrgy, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details and any necessary import documentation.

Nesyrgy combines two mechanisms—calcium‑channel blockade and β1‑adrenergic antagonism—into a single tablet, which can simplify regimens compared with taking separate agents. Compared with monotherapy, the combination may achieve better blood‑pressure control in patients who need both actions, while potentially reducing pill burden and improving adherence.

Nesyrgy tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the container tightly closed and out of reach of children. Do not store in a refrigerator or freezer.

Nesyrgy is taken orally, usually once daily with or without food, as directed by the prescriber. The tablet should be swallowed whole with a glass of water. Patients should not crush, split, or chew the tablet unless specifically instructed by a healthcare professional.

Serious risks include severe hypotension, bradycardia, heart block, hepatic dysfunction, angioedema, and rare allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience symptoms like fainting, rapid weight gain, yellowing of the skin or eyes, swelling of the face or throat, or any signs of an allergic reaction.

Nesyrgy should be avoided in patients with known hypersensitivity to amlodipine, nebivolol, or any excipients, as well as in individuals with severe aortic stenosis, uncontrolled heart failure, or cardiogenic shock. Caution is also advised for patients with significant liver impairment or those taking interacting medications that could cause dangerous blood‑pressure or heart‑rate changes.